Events Search and Views Navigation

Event Views Navigation

Filters

Changing any of the form inputs will cause the list of events to refresh with the filtered results.

Current

BioVie Inc. Virtual KOL Event to Discuss the Phase 2 Study of Bezisterim for the Treatment of Parkinson’s Disease

Join BioVie Inc. for a virtual key opinion leader (KOL) event featuring Suzanne de la Monte, MD, MPH (Brown University…
TIME: 12:00 PM EDT
LOCATION: Virtual
View Details

Inmagene Biopharmaceuticals Virtual KOL Event to Discuss the Potential Role of Anti-OX40/OX40L Monoclonal Antibodies (mAbs) in the Treatment of Alopecia Areata (AA)

Join Inmagene Biopharmaceuticals for a virtual key opinion leader (KOL) event featuring Emma Guttman, MD, PhD (Icahn School of Medicine…
TIME: 11:00 AM EDT
LOCATION: Virtual
View Details

DiaMedica Therapeutics Virtual KOL Event to Discuss DM199 (Rinvecalinase Alfa) for the Treatment of Preeclampsia

Join DiaMedica Therapeutics for a virtual key opinion leader (KOL) event featuring Dr. Baha M. Sibai, Professor (McGovern Medical School at UTHealth…
TIME: 8:00 AM EDT
LOCATION: Virtual
View Details

Cidara Therapeutics Virtual R&D Day to Discuss CD388 as a Potential Universal, Once-Per-Flu Season Preventative of Seasonal and Pandemic Influenza

Join Cidara Therapeutics for a virtual R&D Day featuring key opinion leaders (KOLs) Fred Hayden, MD, FACP (University of Virginia…
TIME: 10:00 AM EDT
LOCATION: Virtual
View Details

Mobilizing the Immune System: Cue Biopharma’s Novel Biologics Portfolio Event

Join Cue Biopharma (CUE) for a virtual event featuring two key opinion leaders (KOLs) Richard DiPaolo, PhD (Saint Louis University) and Andrew Cope,…
TIME: 11:00 AM EDT
LOCATION: Virtual
View Details

Atea Pharmaceuticals Virtual KOL Event to Discuss the Current Challenges for Patients with Hepatitis C, Results from Atea’s Phase 2 Study of the regimen of Bemnifosbuvir and Ruzasvir, and What a New Optimized HCV Therapy Could Provide for Prescribers and Patients

Join Atea Pharmaceuticals for a virtual panel discussion featuring several key opinion leaders (KOLs) including: Eric Lawitz, MD - Texas Liver…
TIME: 10:00 AM EDT
LOCATION: Virtual
View Details

Eupraxia Pharmaceuticals Virtual KOL Event to Discuss the Phase 1b/2a RESOLVE Study of EP-104GI for the Treatment of Eosinophilic Esophagitis (EoE)

Join Eupraxia Pharmaceuticals for a virtual KOL event featuring key opinion leader (KOL) Evan Dellon, MD, MPH (University of North Carolina,…
TIME: 9:00 AM EDT
LOCATION: Virtual
View Details

BioVersys AG Virtual KOL Event: BV100 Shows Survival Benefit in Phase 2 Ventilator Associated Pneumonia (VABP) Study Against Carbapenem Resistant Acinetobacter. What Does that Mean for Patients? A Perspective from the US and from Asia.

Join BioVersys for a virtual key opinion leader (KOL) event featuring Professor David Paterson (ADVANCE-ID, Saw Swee Hock School of…
TIME: 8:30 AM EDT
LOCATION: Virtual
View Details

Theriva™ Biologics VIRAGE Phase 2b Pancreatic Cancer Clinical Trial of VCN-01 Top line Data Update

Details to follow.
TIME: 8:00 AM EDT
LOCATION: Virtual
View Details

Praxis Precision Medicines virtual investor event to discuss clinical programs in Developmental and Epileptic Encephalopathies (DEEs)

Join Praxis Precision Medicines for a virtual investor event hosted by company management, who will focus on their DEE clinical…
TIME: 10:00 AM EDT
LOCATION: Virtual
View Details

Foghorn Therapeutics Virtual Investor Event to Review Key Pipelines Updates in Conjunction with 2025 AACR Meeting

Join Foghorn Therapeutics for a virtual investor event to review updates for FHD-909, a potential first-in-class selective SMARCA2 inhibitor, including…
TIME: 8:00 AM EDT
LOCATION: Virtual
View Details

Relmada Therapeutics Virtual KOL Event to Discuss Topline Phase 2 Data for NDV-01 for High-Grade Non-Muscle Invasive Bladder Cancer (HG-NMIBC) at AUA 2025

Join Relmada Therapeutics for a virtual key opinion leader (KOL) event featuring Boris Chertin, MD (Department of Urology, Shaare Zedek…
TIME: 4:30 PM EDT
LOCATION: Virtual
View Details

Leap Therapeutics Virtual KOL Event to Discuss Sirexatamab (DKN-01) in Second-line Patients with Advanced Microsatellite Stable (MSS) Colorectal Cancer (CRC)

Join Leap Therapeutics for a virtual key opinion leader (KOL) event featuring Zev A. Wainberg, MD (Professor of Medicine at UCLA…
TIME: 2:30 PM EDT
LOCATION: Virtual
View Details

M6P Therapeutics: The Lysosomal Storage Disorders treatment landscape with a focus on Pompe Disease and M6P’s S1S3 co-expression platform technology

Join M6P Therapeutics for a virtual key opinion leader (KOL) event featuring Professor Gregory Enns (Stanford Medicine), who will provide…
TIME: 11:00 AM EDT
LOCATION: Virtual
View Details

Oculis In-Person and Virtual R&D Day on Key Business Updates and the Development Plans for Privosegtor (OCS-05) in Acute Optic Neuritis and Beyond

Join Oculis for an in-person and virtual R&D Day to provide an update on Oculis’ portfolio of innovative late-stage clinical…
TIME: 10:00 AM EDT
LOCATION: InterContinental New York Barclay, 111 E 48th St, New York, NY 10017
View Details

Apnimed Dawn of a New Era for Obstructive Sleep Apnea: How Pharmacotherapy Will Change the Treatment Paradigm

Join Apnimed for a virtual investor event featuring key opinion leaders (KOLs) Douglas Kirsch, MD, FAAN, FAASM (Wake Forest University),…
TIME: 12:00 PM EDT
LOCATION: Virtual
View Details